Gary K. Steinberg

Publication Details

  • DEXTROMETHORPHAN ALTERS CEREBRAL BLOOD-FLOW AND PROTECTS AGAINST CEREBRAL INJURY FOLLOWING FOCAL ISCHEMIA NEUROSCIENCE LETTERS Steinberg, G. K., Lo, E. H., Kunis, D. M., Grant, G. A., Poljak, A., Delapaz, R. 1991; 133 (2): 225-228

    Abstract:

    The effects of the N-methyl-D-aspartate (NMDA) antagonist dextromethorphan (DM) on regional cerebral blood flow (rCBF) and cerebral injury were studied in a rabbit model of transient focal ischemia. Anesthetized rabbits underwent 2 h occlusion of the left internal carotid, middle cerebral and anterior cerebral artery, followed by 4 h of reperfusion. Ten minutes after the onset of ischemia they were treated with either i.v. DM 20 mg/kg followed by 10 mg/kg/h (n = 6) or normal saline (NS, n = 5). Control rabbits received DM (n = 3) or NS (n = 2) infusion without arterial occlusion. DM attenuated the sharp, post-ischemic rise in rCBF seen during reperfusion within the ischemic core of NS controls (DM 31% pre-ischemic value, NS 92%). DM also improved the delayed post-ischemic hypoperfusion compared with controls. DM infusion without arterial occlusion did not change rCBF values. Compared with NS controls, DM treated animals demonstrated recovery of the somatosensory evoked potential (DM 96% pre-ischemic values, NS 24%), 76% reduction in cortical edema and 92% decrease in cortical ischemic neuronal damage. We conclude that DM's effect on CBF may contribute to its neuroprotective action.

    View details for Web of Science ID A1991GX48400019

    View details for PubMedID 1816501

Stanford Medicine Resources:

Footer Links: